XML 27 R17.htm IDEA: XBRL DOCUMENT v3.23.1
Stock-Based Compensation (Tables)
9 Months Ended
Mar. 31, 2023
Stock-Based Compensation [Abstract]  
Schedule of restricted stock awards
   March 31, 2023 
   Three Months Ended   Nine Months Ended 
   Number of
Shares
   Weighted
Average
Grant Date
Fair Value
per Price
   Number of
Shares
   Weighted
Average
Grant Date
Fair Value
per Price
 
Beginning balance   296,022   $1.95    344,426   $1.90 
Issued   
-
    
-
    150,000   $2.00 
Vested   (124,202)  $1.93    (322,606)  $1.92 
Forfeited   
-
    
-
    
-
    
-
 
Ending balance   171,820   $1.95    171,820   $1.95 

 

   March 31, 2022 
   Three Months Ended   Nine Months Ended 
   Number of
Shares
   Weighted
Average
Grant Date
Fair Value
per Price
   Number of
Shares
   Weighted
Average
Grant Date
Fair Value
per Price
 
Beginning balance   517,828   $1.90    691,232   $1.90 
Issued   
-
    
-
    
-
    
-
 
Vested   (86,702)  $1.90    (260,106)  $1.90 
Forfeited   
-
    
-
    
-
    
-
 
Ending balance   431,126   $1.90    431,126   $1.90 

 

Schedule of estimates the fair value of each option award
   Nine Months Ended
March 31,
 
   2023    2022     
Weighted-average fair value  $2.49   $1.48 
Expected volatility   100%   100%
Expected term   5.0 years - 7.0 years    5.0 years
Dividend yield   0.00%   0.00%
Risk-free interest rate   1.26% - 4.24%   1.15% - 2.41%

 

Schedule of summarizing employee and non-employee stock option activity
   Number of Options   Weighted
Average
Exercise Price
   Aggregate
Intrinsic
Value (1)
 
Outstanding at January 1, 2023   858,750   $2.01   $846,250 
Granted   147,250   $3.00      
Exercised   
-
    
-
      
Expired/cancelled   -    
-
      
Outstanding at March 31, 2023   1,006,000   $2.16   $1,449,850 
Exercisable at March 31, 2023   307,375   $2.02   $486,613 

 

   Number of Options   Weighted Average
Exercise Price
   Aggregate Intrinsic
Value
 
Outstanding at January 1, 2022   270,000   $2.00   $
      -
 
Granted   34,750   $2.00      
Exercised   
-
    
-
      
Expired/cancelled   
-
    
-
      
Outstanding at March  31, 2022   304,750   $2.00   $
-
 
Exercisable at March 31, 2022   47,500   $2.00   $
-
 

 

   Number of Options   Weighted Average
Exercise Price
   Aggregate Intrinsic
Value (1)
 
Outstanding at July 1, 2022   817,750   $2.00   $
-
 
Granted   308,250   $2.41      
Exercised   
-
    
-
      
Expired/cancelled   (120,000)  $2.00      
Outstanding at March 31, 2023   1,006,000   $2.16   $1,449,850 
Exercisable at March 31, 2023   307,375   $2.02   $486,613 

 

   Number of Options   Weighted Average Exercise Price   Aggregate Intrinsic
Value
 
Outstanding at July 1, 2021   
-
   $
-
   $
          -
 
Granted   304,750   $2.00      
Exercised   
-
    
-
      
Expired/cancelled   -    
-
      
Outstanding at March  31, 2022   304,750   $2.00   $
-
 
Exercisable at March 31, 2022   47,500   $2.00   $
-